If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.10    0.00 (0.00%)
Bid:
0.09
Ask:
0.11
Spread: 0.02 (22.222%)
Market Cap: £1.48m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Key Licence Conversion, Weald Basin

5 Jul 2016 07:00

RNS Number : 2131D
Evocutis PLC
05 July 2016
 

 

Evocutis plc

("Evocutis" or the "Company")

Key Licence Conversion, Kimmeridge and Portland Region, Weald Basin

 

 

Evocutis (AIM: EVO, ISDX: EVO) is pleased to announce that the Oil and Gas Authority ("OGA") has granted a licence conversion to new model terms for Horse Hill ("HH") PEDL137 and PEDL246.

At the Operator Horse Hill Developments Ltd's ("HHDL") election, the licences will adopt 2016 14th Round licence terms permitting the HH Licences to continue without further relinquishment. A Retention Area ("RA") covering the entire 55 square mile licence area and an outline work programme has been agreed with the OGA. The RA will continue throughout the agreed work programme period currently due to expire on June 30, 2018 for PEDL137 and June 30, 2017 for PEDL246. The HH Licences forward work plan includes long-term production testing of 3 Kimmeridge Limestone zones plus the overlying Portland, two contingent appraisal/development wells and 3D seismic.

Interest in Horse Hill

Evocutis owns a 2% direct interest in HHDL. HHDL is a special purpose company that owns a 65% participating interest and operatorship of Licence PEDL137 and the adjacent Licence PEDL246 in the UK Weald Basin.

 

Qualified Person's Statement:

Stephen Sanderson, who has over 35 years of relevant experience in the oil industry, has approved the information contained in this announcement. Mr Sanderson is a Fellow of the Geological Society of London and is an active member of the American Association of Petroleum Geologists.

 

For further information please contact:

 

Evocutis plc:

+44 (0) 20 7440 0640

Hamish Harris

Nominated Adviser and Broker:

+44 (0) 20 7148 7900

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGGNMDKGVZZ
Date   Source Headline
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.